A daily quiz series presents five questions focusing on lymphatic filariasis elimination in India and related topics. The questions cover drug combinations used in Mass Drug Administration (MDA), functions of the lymphatic system, diagnostic imaging techniques, global elimination programmes, and manual lymphatic drainage therapy.
Questions and Answers
Q1. Mass Drug Administration (MDA) for lymphatic filariasis elimination in India uses which combination of drugs?
Answer: (b) DEC and Albendazole. India's MDA strategy uses Diethylcarbamazine (DEC) combined with Albendazole to interrupt filarial transmission.
Q2. Which of the following functions is NOT performed by the lymphatic system?
Answer: (b) Transporting oxygen to body tissues. Oxygen transport is exclusively a function of the cardiovascular system via haemoglobin in red blood cells. The lymphatic system does not carry oxygen.
Q3. Indocyanine green lymphography is used to:
Answer: (b) Assess the functioning and congestion of lymphatic vessels. Indocyanine green lymphography is a specialised imaging technique that visualises lymphatic flow and identifies areas of congestion or damage.
Q4. The WHO's Global Programme to Eliminate Lymphatic Filariasis (GPELF) primarily aims to:
Answer: (b) Interrupt transmission and alleviate suffering through MDA and morbidity management. GPELF combines MDA to stop transmission with morbidity management and disability prevention (MMDP) to reduce the burden on those already affected.
Q5. With reference to manual lymphatic drainage (MLD), which of the following statements is most accurate based on current scientific evidence?
Answer: (c) MLD may support lymphatic flow but shows limited efficacy when used in isolation, and is best combined with compression and exercise. Evidence supports MLD as a supplementary therapy within a multimodal approach, but not as an independent treatment with significant or lasting outcomes.
Key Takeaways
This quiz highlights important aspects of lymphatic filariasis elimination efforts in India, including the use of DEC and Albendazole in MDA, the role of the lymphatic system in immune response and lipid absorption but not oxygen transport, the utility of indocyanine green lymphography for assessing lymphatic vessel function, the dual goals of GPELF in transmission interruption and morbidity management, and the evidence-based use of manual lymphatic drainage as part of a comprehensive treatment plan for lymphoedema.
